Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Respir Med Retrieve available abstracts of 294 articles: HTML format

Single Articles

November 2025
1. ZHANG S, Shen K, Sun B, Liu B, et al
   Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
   Respir Med. 2025;248:108422.
   PubMed     Abstract available
   
   
   
2. HANSEN FR, Pedersen DC, Madsen F, Backman H, et al
   Childhood body size and risk of chronic obstructive pulmonary disease in adulthood: a prospective cohort study.
   Respir Med. 2025;248:108416.
   PubMed     Abstract available
   
   
   
3. HARRISON SL, Loughran KJ, Suri S, Franklin A, et al
   The continuous daily work of living with chronic obstructive pulmonary disease: An ethnographic study.
   Respir Med. 2025;248:108405.
   PubMed     Abstract available
   
   
   
4. ZHANG X, Xue J, Chang Y, Zhang R, et al
   Non-pharmacological interventions for fatigue in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis.
   Respir Med. 2025;248:108409.
   PubMed     Abstract available
   
   
   
5. MATERA MG, Page C, Cazzola M
   Sarcopenia as a treatable trait in COPD: From mechanisms to management.
   Respir Med. 2025;248:108401.
   PubMed     Abstract available
   
   
   
6. BAKAKOS A, Sotiropoulou Z, Anagnostopoulos N, Vontetsianos A, et al
   Anti-inflammatory agents for the management of COPD - Quo Vadis?
   Respir Med. 2025;248:108396.
   PubMed     Abstract available
   
   
   
7. CHOI JY, Yoon HK, Kim Y, Jang JG, et al
   Comparison of chronic bronchitis definitions in COPD for predicting 10-year all-cause mortality.
   Respir Med. 2025;248:108389.
   PubMed     Abstract available
   
   
   
8. WANG H, Fan M, Wu J, Liu H, et al
   Development of a questionnaire on supportive care needs of patients with COPD combined with respiratory failure on noninvasive ventilators and evaluating its reliability and validity.
   Respir Med. 2025;248:108384.
   PubMed     Abstract available
   
   
   
9. KARAKURT G, Demireller M, Ucgun H, Guven O, et al
   EzPAP therapy versus non-invasive ventilation for hypercapnic chronic obstructive pulmonary disease exacerbation: a randomized clinical trial.
   Respir Med. 2025;248:108383.
   PubMed     Abstract available
   
   
   
10. ALVAREZ-MARTINEZ CJ, Hernandez M, Velez J, Sanchez-Covisa J, et al
    Clinical and economic impact of concomitant heart failure in patients with exacerbated COPD.
    Respir Med. 2025;248:108381.
    PubMed     Abstract available
    
    
    
11. WU SC, Wu CY, Chien JY, Dong YH, et al
    Predicting response to inhaled corticosteroid maintenance therapy in patients with chronic obstructive pulmonary disease using machine learning models.
    Respir Med. 2025;248:108378.
    PubMed     Abstract available
    
    
    
12. TSILIGIANNI I, Papageorgakopoulou S, Bouloukaki I
    Adherence to the Chronic Obstructive Pulmonary Disease guidelines in primary care: The Greek COPD COCARE study.
    Respir Med. 2025;248:108345.
    PubMed     Abstract available
    
    
    
13. NIELSEN LB, Olsson M, Weinreich UM, Ekstrom M, et al
    Associations between chronic airflow limitation, respiratory symptoms, and quality of life across alcohol use categories: a population based study.
    Respir Med. 2025;248:108350.
    PubMed     Abstract available
    
    
    
14. SUTER P, Greig R, Chan R, Lipworth B, et al
    Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials.
    Respir Med. 2025;248:108343.
    PubMed     Abstract available
    
    
    
15. BHUTANI M, Mullerova H, Patel D, Barjaktarevic I, et al
    Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States.
    Respir Med. 2025;248:108337.
    PubMed     Abstract available
    
    
    
16. CAZZOLA M, Hanania NA, Rogliani P
    Comorbidities as treatable traits of chronic airway diseases.
    Respir Med. 2025;248:108333.
    PubMed     Abstract available
    
    
    
17. MOUROUVIN-CHEVOLOT E, Laurent L, Claude F, Westeel V, et al
    Distinctive computed tomography features of chronic obstructive pulmonary disease among dairy farmers and smokers.
    Respir Med. 2025;248:108319.
    PubMed     Abstract available
    
    
    
18. SEPULVEDA-LOYOLA W, Tang C, Alvarez-Bustos A, Cuyul-Vasquez I, et al
    Exploring pulmonary rehabilitation programs implemented and conducted in Latin America for people with chronic respiratory conditions: A scoping review.
    Respir Med. 2025;248:108310.
    PubMed     Abstract available
    
    
    
19. SANCHEZ FM, Bommatty MS, Haro MQ, Ruiz FO, et al
    Telemonitoring in patients with COPD: A prospective study with results from the AIRE project.
    Respir Med. 2025;248:108307.
    PubMed     Abstract available
    
    
    October 2025
20. KOWALCZYK ET, Medubi KM, Meyer MJ, Toriola MA, et al
    Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates.
    Respir Med. 2025 Oct 22:108449. doi: 10.1016/j.rmed.2025.108449.
    PubMed     Abstract available
    
    
    
21. MACKLE R, Crespo-Gonzalez C, Gray M, Chan M, et al
    Implementing enhanced paediatric asthma care in rural Australia: Qualitative insights from healthcare professionals.
    Respir Med. 2025;249:108444.
    PubMed     Abstract available
    
    
    
22. DA SILVA LIMA D, Rechenmacher C, Bernardi J, Velleda de Morais R, et al
    SMAD3 gene methylation profile and asthma in childhood: A longitudinal approach.
    Respir Med. 2025;249:108424.
    PubMed     Abstract available
    
    
    
23. SUTER P, Greig R, Kuo CR, Chan R, et al
    Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
    Respir Med. 2025 Oct 7:108402. doi: 10.1016/j.rmed.2025.108402.
    PubMed     Abstract available
    
    
    
24. ARARAT E, Rastogi D, Martin BC
    Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels.
    Respir Med. 2025 Oct 6:108403. doi: 10.1016/j.rmed.2025.108403.
    PubMed     Abstract available
    
    
    
25. MURAOKA H, Tsuburai T, Komase Y, Tanaka S, et al
    Association between 6-min walk test and initiation of home oxygen therapy within 3 years in chronic obstructive pulmonary disease managed by primary care physicians.
    Respir Med. 2025;247:108317.
    PubMed     Abstract available
    
    
    
26. DETTORAKI M, Vandorou KT, Tsoukalas D, Basagianni E, et al
    Ocular manifestations in COPD patients. An underrecognized comorbidity.
    Respir Med. 2025;247:108313.
    PubMed     Abstract available
    
    
    
27. CAI S, Huang Q, Huang M, Wang J, et al
    Association of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study.
    Respir Med. 2025;247:108300.
    PubMed     Abstract available
    
    
    
28. CAZZOLA M, Maniscalco M, Patella V, Calzetta L, et al
    Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes.
    Respir Med. 2025;247:108292.
    PubMed     Abstract available
    
    
    
29. CANDIA C, Fuschillo S, Ambrosino P, Motta A, et al
    Exercise-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: What is the potential role of biomarkers? A narrative review.
    Respir Med. 2025;247:108282.
    PubMed     Abstract available
    
    
    
30. DU BERRY C, Simpson SJ, Spittle AJ, Holland AE, et al
    Exercise training to address lifelong consequences of preterm birth: a survey of perceived needs.
    Respir Med. 2025;247:108284.
    PubMed     Abstract available
    
    
    
31. NIEDERMAIER T, Alter P, Jorres R, Vogelmeier C, et al
    Parametric estimation of age-, sex-, and spirometry grade-specific mortality in a cohort of COPD patients from Germany: Results from COSYCONET.
    Respir Med. 2025;247:108280.
    PubMed     Abstract available
    
    
    
32. BECK DA SILVA ETGES AP, Marcolino MAZ, Bianchini L, Kawano-Dourado L, et al
    Economic analysis of high-flow nasal oxygen compared with noninvasive ventilation in patients with acute respiratory failure: results from the RENOVATE randomized clinical trial.
    Respir Med. 2025;247:108270.
    PubMed     Abstract available
    
    
    
33. VILLAR-AGUILAR L, Casal-Guisande M, Fernandez-Villar A, Garcia-Rodriguez E, et al
    Characterisation of patients with Alpha-1 antitrypsin deficiency using unsupervised machine learning tools.
    Respir Med. 2025;247:108278.
    PubMed     Abstract available
    
    
    
34. SHAHID H, Ahmed M, Sami SZ, Kumar S, et al
    High-intensity versus low-intensity non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;247:108277.
    PubMed     Abstract available
    
    
    
35. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    PubMed     Abstract available
    
    
    
36. EGGLESTON RH, Torghabeh MH, Niven AS, Lim KG, et al
    Bronchodilator Response: Utility and implications in patients undergoing hematopoietic stem cell transplantation.
    Respir Med. 2025;247:108259.
    PubMed     Abstract available
    
    
    
37. BUENDIA JA, Manrique Acevedo LF, Celis Preciado C
    "Beyond triple Therapy: Is dupilumab a cost-effective option for COPD with type 2 inflammation?".
    Respir Med. 2025;247:108254.
    PubMed     Abstract available
    
    
    September 2025
38. BROZEK G, Nowak B, Prendergast C, Gil A, et al
    Thirty year trends in childhood asthma and allergic conditions in Poland.
    Respir Med. 2025;248:108379.
    PubMed     Abstract available
    
    
    
39. ALAM ABMN, Gill N, AlAshoor M, Cherif I, et al
    SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
    Respir Med. 2025;248:108357.
    PubMed     Abstract available
    
    
    
40. FABOZZI A, Bouloukaki I, Bonini M, Schiza SE, et al
    Asthma-OSA overlap syndrome: A distinct endophenotype?
    Respir Med. 2025;248:108344.
    PubMed     Abstract available
    
    
    
41. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    PubMed     Abstract available
    
    
    
42. DAL NEGRO RW, Turco P, Povero M
    Sensitivity and specificity of various lung function parameters recommended for phenotyping COPD in clinical practice.
    Respir Med. 2025;246:108256.
    PubMed     Abstract available
    
    
    
43. FERRAZ BD, Faria N, Lacerda C, Mona D, et al
    Spirometry to predict dry powder inhaler performance: Insights from in-check DIAL.
    Respir Med. 2025;246:108249.
    PubMed     Abstract available
    
    
    
44. BAJPAI J, Kant S, Matera MG, Cazzola M, et al
    Targeting neutrophilic inflammation in obstructive airway disease - A narrative review of brensocatib therapy.
    Respir Med. 2025;246:108243.
    PubMed     Abstract available
    
    
    
45. WANG JG, Colangelo LA, Meislin R, Khan SS, et al
    Adverse pregnancy outcomes and lung function later in life: The CARDIA lung study.
    Respir Med. 2025;246:108244.
    PubMed     Abstract available
    
    
    
46. BJORKLUND F, Palm A, Sundh J, Ekstrom M, et al
    A lung function threshold for survival? - FEV(1)Q and mortality in patients with COPD and chronic respiratory failure.
    Respir Med. 2025;246:108242.
    PubMed     Abstract available
    
    
    
47. BAMONTI PM, Wingood M, Robinson SA, Rose GA, et al
    Psychometric evaluation of the exercise self-regulatory efficacy scale using objective measures of physical functioning in persons with chronic obstructive pulmonary disease.
    Respir Med. 2025;246:108228.
    PubMed     Abstract available
    
    
    
48. MARQUES A, Antao J, Rodrigues G, Paixao C, et al
    Pulmonary rehabilitation in minimal versus high resource settings in COPD: a non-inferiority and economic evaluation.
    Respir Med. 2025;246:108229.
    PubMed     Abstract available
    
    
    
49. LI Y, Li X, Li Z, Luo T, et al
    Visceral fat-to-muscle mass ratio to predict cardiovascular events and mortality in patients with chronic obstructive pulmonary disease: A prospective cohort study.
    Respir Med. 2025;246:108215.
    PubMed     Abstract available
    
    
    
50. HOLM KE, Sandhaus RA, Allison S, Schroth T, et al
    Sleep apnea among individuals with Alpha-1 antitrypsin deficiency-associated lung disease.
    Respir Med. 2025;246:108217.
    PubMed     Abstract available
    
    
    August 2025
51. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    PubMed     Abstract available
    
    
    
52. OLIVEIRA JM, Urroz Guerrero PD, Lewthwaite H, Clark VL, et al
    Safety of the 6-minute walk test in adults with severe asthma.
    Respir Med. 2025 Aug 21:108316. doi: 10.1016/j.rmed.2025.108316.
    PubMed     Abstract available
    
    
    
53. BRIDEVAUX PO, Bourdin A, VAN Ganse E
    Substantial Reduction in Oral Corticosteroid Use After Biologics Initiation in Severe Asthma: An Analysis Based on Swiss Pharmacy Data.
    Respir Med. 2025 Aug 21:108312. doi: 10.1016/j.rmed.2025.108312.
    PubMed     Abstract available
    
    
    
54. GREIG R, Suter P, Chan R, Lipworth B, et al
    Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
    Respir Med. 2025;247:108315.
    PubMed     Abstract available
    
    
    
55. CHAN R, Cottini M, Menzella F, Poto R, et al
    Body mass index and lung function decline in persistent asthma.
    Respir Med. 2025 Aug 11:108304. doi: 10.1016/j.rmed.2025.108304.
    PubMed    
    
    
    
56. HOGAARD NV, Sigsgaard T, Agertoft L, Halken S, et al
    Effect of indoor environmental interventions in the home on asthma in children and adolescents: A systematic review.
    Respir Med. 2025 Aug 5:108299. doi: 10.1016/j.rmed.2025.108299.
    PubMed     Abstract available
    
    
    
57. PATEL C, Sheth V, Koppula R, Kumar A, et al
    Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa
    Respir Med. 2025;247:108293.
    PubMed     Abstract available
    
    
    
58. TU D, Ju S, Xue Y, Xie W, et al
    Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011-2023.
    Respir Med. 2025;247:108288.
    PubMed     Abstract available
    
    
    
59. HSU CC, Tung PH, Lin TY, Huang SW, et al
    Effect of chronic kidney disease on survival in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;244:108181.
    PubMed     Abstract available
    
    
    
60. ELLINGSEN J, Janson C, Broms K, Farkhooy A, et al
    Clinical phenotypes predict exacerbations of COPD: the TIE cohort study.
    Respir Med. 2025;244:108182.
    PubMed     Abstract available
    
    
    
61. HOCHHAUSEN N, Moza A, Kroh A, Rossaint R, et al
    Chronic obstructive pulmonary disease is associated with a higher incidence of acute kidney injury in non-cardiac but not in cardiac surgery ICU-patients: a retrospective MIMIC-III database analysis.
    Respir Med. 2025;244:108160.
    PubMed     Abstract available
    
    
    
62. QU M, Yang L, Liu K, Tang T, et al
    The effectiveness and feasibility of virtual pulmonary rehabilitation in patients with chronic respiratory diseases: A systematic review and meta-analysis.
    Respir Med. 2025;244:108159.
    PubMed     Abstract available
    
    
    
63. FAHRENBERG C, Niedermaier T, Alter P, Jorres RA, et al
    Analysis of change in health-related quality of life in patients with COPD over 6 years, including information on dropouts: Results from the German COSYCONET cohort.
    Respir Med. 2025;244:108153.
    PubMed     Abstract available
    
    
    
64. ZHU B, Xue F, Li M, Chen Y, et al
    Long-term benefits of pulmonary rehabilitation with respiratory muscle training in people with COPD: A retrospective cohort study.
    Respir Med. 2025;245:108214.
    PubMed     Abstract available
    
    
    
65. GIRI M, Puri A, Chen Y, Liu Y, et al
    Association between Pan-immune-inflammation value and in-hospital mortality in critically ill patients with Chronic obstructive pulmonary disease: An observational study.
    Respir Med. 2025;245:108213.
    PubMed     Abstract available
    
    
    
66. ZHANG Y, Chen H, Hu S, Chen C, et al
    Construction and validation of a nomogram prediction model for death risk in patients with chronic obstructive pulmonary disease complicated by hypercapnic respiratory failure in the intensive care unit.
    Respir Med. 2025;245:108188.
    PubMed     Abstract available
    
    
    
67. COLEMAN KM, Varrias D, Wolf E, Schwartz J, et al
    Unrecognized actionable cardiac arrhythmias in patients with moderate to severe chronic obstructive pulmonary Disease: Can continuous monitoring unmask the culprit.
    Respir Med. 2025;245:108190.
    PubMed     Abstract available
    
    
    
68. HU Y, Hu Y, Dong M, Zheng S, et al
    Integrating clinical phenotypes, impulse oscillometry and fractional exhaled nitric oxide: a robust machine learning model for early asthma prediction in preschool children.
    Respir Med. 2025 Aug 1:108290. doi: 10.1016/j.rmed.2025.108290.
    PubMed     Abstract available
    
    
    July 2025
69. TIRELLI C, Parazzini EM, Sacchi L, Carone G, et al
    Forced Oscillatory Technique R5-19 values correlate with spirometry FEV1/FVC in severe eosinophilic asthma. An observational, prospective, cohort study.
    Respir Med. 2025 Jul 16:108260. doi: 10.1016/j.rmed.2025.108260.
    PubMed     Abstract available
    
    
    
70. PARK HJ, Lee CH, Lee JK, Kim DK, et al
    Radiologic emphysema predicts accelerated lung function decline in patients with asthma.
    Respir Med. 2025;247:108261.
    PubMed     Abstract available
    
    
    
71. TIAN C, Xiong S, Song X, Li S, et al
    Spirometry and impulse oscillometry in the diagnosis of cough variant asthma in children.
    Respir Med. 2025;246:108255.
    PubMed     Abstract available
    
    
    
72. KOH MS, Xu X, Wei Lam SS, Wu JT, et al
    Public health insights of patients with asthma receiving primary, specialist or mixed care in Singapore using data from the SDG-CARE Asthma Registry.
    Respir Med. 2025 Jul 11:108252. doi: 10.1016/j.rmed.2025.108252.
    PubMed     Abstract available
    
    
    
73. ACHTERBOSCH M, Hansen CME, Brand PLP, van Dijk L, et al
    Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review.
    Respir Med. 2025 Jul 11:108251. doi: 10.1016/j.rmed.2025.108251.
    PubMed    
    
    
    
74. KISIEL MA, Zhou X, Fundberg I, Barrling A, et al
    Mortality and its predictive factors in participants with asthma: a 26-year follow-up.
    Respir Med. 2025;246:108253.
    PubMed     Abstract available
    
    
    
75. BRAIDO F, Beeh KM, Serrano CC, Dinh-Xuan AT, et al
    Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler(R) and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study.
    Respir Med. 2025 Jul 9:108224. doi: 10.1016/j.rmed.2025.108224.
    PubMed     Abstract available
    
    
    
76. DIEZ SIERRA J, Medina Gallardo JF, Munoz Sanchez B, Leon Lloreda A, et al
    FEV(1) Decline and Clinical Predictors in Asthma after 10 Years of Follow-Up: BMI as a Modifiable Risk Factor.
    Respir Med. 2025 Jul 4:108247. doi: 10.1016/j.rmed.2025.108247.
    PubMed     Abstract available
    
    
    
77. AKSAMIT TR, Choate R, Mannino DM, Brunton AE, et al
    Natural history and burden of refractory Mycobacterium avium complex pulmonary disease: insights from the US Bronchiectasis and Nontuberculous Mycobacterial Research Registry.
    Respir Med. 2025 Jul 2:108220. doi: 10.1016/j.rmed.2025.108220.
    PubMed     Abstract available
    
    
    
78. SHINGAI K, Ikeuchi T, Rassam P, Kozu R, et al
    Development of a new ambulatory oxygen delivery method combining continuous oxygen flow and demand oxygen delivery system: A prospective, single-blind, randomized crossover trial.
    Respir Med. 2025;243:108140.
    PubMed     Abstract available
    
    
    
79. MAHAJAN AK, Collar N, Muldowney F, Ochoa Cuba MA, et al
    Incidence and outcomes for post-bronchoscopic lung volume reduction (BLVR) pneumothoraces stratified by target lobe treated.
    Respir Med. 2025;243:108148.
    PubMed     Abstract available
    
    
    
80. ANYETEI-ANUM GP, White B, Yadav H, Kennedy CC, et al
    Effect of native lung disease on post-transplant best lung function.
    Respir Med. 2025;243:108128.
    PubMed     Abstract available
    
    
    
81. MEKONNEN TC, Melaku YA, Shi Z, Gill TK, et al
    Joint analysis of diet quality, inflammatory potential of diet and ultra-processed food exposure in relation to chronic respiratory diseases and lung cancer mortality.
    Respir Med. 2025;243:108138.
    PubMed     Abstract available
    
    
    
82. ROMERO-LINARES A, Alvarez-Muro L, Hammadi A, Hoyas-Sanchez C, et al
    Short term exacerbation risk and exhaled nitric oxide in COPD.
    Respir Med. 2025;243:108134.
    PubMed     Abstract available
    
    
    
83. LOUGHRAN KJ, Trewartha G, Martin D, Fernandes-James C, et al
    Persistent pain is associated with poorer balance and gait performance for people with Chronic Obstructive Pulmonary Disease.
    Respir Med. 2025;243:108133.
    PubMed     Abstract available
    
    
    
84. KLAPS S, Langer D, Gosselink R, Dacha S, et al
    The value of extra-diaphragmatic inspiratory muscle surface electromyography during postural control tasks in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;243:108127.
    PubMed     Abstract available
    
    
    
85. HANSEN H, Godtfredsen N, Ulrik CS, Hansen J, et al
    Physical activity levels in Danish adults with and without asthma - A national recurrent cross-sectional case-control study from 2010 to 2021.
    Respir Med. 2025 Jul 1:108240. doi: 10.1016/j.rmed.2025.108240.
    PubMed     Abstract available
    
    
    June 2025
86. ZHU W, Chen K, Xiang Y, Shi J, et al
    Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis.
    Respir Med. 2025 Jun 26:108223. doi: 10.1016/j.rmed.2025.108223.
    PubMed     Abstract available
    
    
    
87. ANTAO J, Rodrigues G, Deng Q, Baak BN, et al
    Trends in initial pharmacological treatment of asthma in primary care (2010-2021): A population-based study using the PHARMO data network.
    Respir Med. 2025;246:108222.
    PubMed     Abstract available
    
    
    
88. ZHENG X, Jiang H, Cui R, Cai A, et al
    From Itchy Skin to Wheezing: Potential biomarkers and targeted drugs for Atopic Dermatitis and Asthma in Children.
    Respir Med. 2025 Jun 13:108212. doi: 10.1016/j.rmed.2025.108212.
    PubMed     Abstract available
    
    
    
89. FREUND O, Hadad Y, Bergeron A, Fried S, et al
    Bronchiectasis after allogeneic hematopoietic cell transplantation - an underdiagnosed complication.
    Respir Med. 2025;245:108208.
    PubMed     Abstract available
    
    
    
90. HANSEN S, Hakansson KEJ, Soendergaard MB, Bjerrum AS, et al
    Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.
    Respir Med. 2025 Jun 11:108203. doi: 10.1016/j.rmed.2025.108203.
    PubMed     Abstract available
    
    
    
91. PINI L, Caminati M, Maule M, Bagnasco D, et al
    ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.
    Respir Med. 2025;245:108198.
    PubMed     Abstract available
    
    
    
92. BRAUNWALDER C, Ertl J, Wullschleger M, Timm E, et al
    Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: A systematic review.
    Respir Med. 2025 Jun 7:108202. doi: 10.1016/j.rmed.2025.108202.
    PubMed     Abstract available
    
    
    
93. TAY TR, Pang E, Liew MF, Tiew PY, et al
    Ethnic variation in South East Asian patients with Severe Asthma: A First Look at the Singapore Severe Asthma Registry (SSAR) and implications on clinical practice.
    Respir Med. 2025 Jun 5:108199. doi: 10.1016/j.rmed.2025.108199.
    PubMed     Abstract available
    
    
    
94. COOPER DH, Akbarian N, Aaron SD, Luks V, et al
    Glucagon-like Peptide 1 (GLP-1) Receptor Agonists and Asthma and COPD Exacerbations in Adults with Diabetes: A Systematic Review.
    Respir Med. 2025 Jun 4:108197. doi: 10.1016/j.rmed.2025.108197.
    PubMed     Abstract available
    
    
    
95. LI H, Huang X, Wei Z, Chen Z, et al
    Unveiling genetic links: GSDMB polymorphisms and asthma susceptibility in the Zhuang Nationality of Guangxi.
    Respir Med. 2025;245:108176.
    PubMed     Abstract available
    
    
    
96. MATTA A, Polychronopoulou E, Kuo YF, Sharma G, et al
    Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014-2019.
    Respir Med. 2025;242:108110.
    PubMed     Abstract available
    
    
    
97. LIGUORO I, Patui M, Vidoni M, Pilotto C, et al
    Comparison of the sensitivity and specificity of bronchiolitis severity scores in infants: a systematic review and meta-analysis.
    Respir Med. 2025;242:108111.
    PubMed     Abstract available
    
    
    
98. BENFANTE A, Tomasello A, Pitruzzella A, Fucarino A, et al
    Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model.
    Respir Med. 2025;242:108107.
    PubMed     Abstract available
    
    
    
99. JALALVAND M, Tahermohammadi H, Madreseh E, Varahram M, et al
    Regulatory T cells in the blood of patients with chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis.
    Respir Med. 2025;242:108104.
    PubMed     Abstract available
    
    
    
100. FANDOS VAZQUEZ P, Diez-Manglano J
     Thyroid hormones in people with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
     Respir Med. 2025;242:108103.
     PubMed     Abstract available
     
     
     
101. PIERRE C, Jeanne I, Mathieu B, Hugo G, et al
     Characteristics and risk factors of intubation in COPD patients with severe acute exacerbation: An exploratory single-center retrospective study.
     Respir Med. 2025;242:108095.
     PubMed     Abstract available
     
     
     May 2025
102. HANANIA NA, Stanford R, Rendon A, Gemicioglu B, et al
     Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control - a retrospective United States database analysis.
     Respir Med. 2025 May 28:108172. doi: 10.1016/j.rmed.2025.108172.
     PubMed     Abstract available
     
     
     
103. ZHANG X, Zhang X, Wan Y, Xu D, et al
     The association between alpha-1-acid glycoprotein and asthma in United States: a cross-sectional study from NHANES.
     Respir Med. 2025;245:108174.
     PubMed     Abstract available
     
     
     
104. ATALAY NA, Yormaz B, Sahin A, Sonmez G, et al
     Elevated HIF-1alpha as a Diagnostic Biomarker in COPD: Correlations with EPO, Emphysema Index, and Pulmonary Function.
     Respir Med. 2025 May 28:108184. doi: 10.1016/j.rmed.2025.108184.
     PubMed     Abstract available
     
     
     
105. COTTINI M, Poto R, Bhattacharjee A, Galant S, et al
     Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.
     Respir Med. 2025 May 27:108180. doi: 10.1016/j.rmed.2025.108180.
     PubMed     Abstract available
     
     
     
106. DOUMAT G, Aksamit TR, Kanj AN
     Bronchiectasis: A clinical review of inflammation.
     Respir Med. 2025;244:108179.
     PubMed     Abstract available
     
     
     
107. MOCHIZUKI F, Tanabe N, Iijima H, Shimada T, et al
     Prediction of airflow limitation in smokers using multiple CT imaging indices: airway wall thickness, quantitative emphysema, and visually identified centrilobular emphysema.
     Respir Med. 2025 May 20:108169. doi: 10.1016/j.rmed.2025.108169.
     PubMed     Abstract available
     
     
     
108. XIANG J, Cui M
     Neutrophil Extracellular Traps and neutrophilic asthma.
     Respir Med. 2025 May 12:108150. doi: 10.1016/j.rmed.2025.108150.
     PubMed     Abstract available
     
     
     
109. LEMACON C, Lopes AA
     Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments.
     Respir Med. 2025 May 8:108152. doi: 10.1016/j.rmed.2025.108152.
     PubMed     Abstract available
     
     
     
110. MOERMANS C, Decerf N, Javaux N, Onssels A, et al
     High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor.
     Respir Med. 2025 May 7:108151. doi: 10.1016/j.rmed.2025.108151.
     PubMed     Abstract available
     
     
     
111. ZHONG Z, Zhang C, Zhao L, Zhao Y, et al
     Inhaled tobramycin in non-cystic fibrosis bronchiectasis: A meta-analysis of randomized controlled trials.
     Respir Med. 2025 May 6:108136. doi: 10.1016/j.rmed.2025.108136.
     PubMed     Abstract available
     
     
     
112. WENNERGREN G, Lindberg A, Kauppi P, Kankaanranta H, et al
     Glimpses of diagnostic tools and treatment of asthma in Sweden, Norway, and Finland from a medico-historical perspective.
     Respir Med. 2025;243:108139.
     PubMed     Abstract available
     
     
     
113. BULKHI AA, Elkkari A, Alghamdi BJ, Mahboub B, et al
     Defining Clinical Remission in Severe Asthma: Expert Opinion from the Gulf Region Using the Modified Delphi Method.
     Respir Med. 2025 May 3:108132. doi: 10.1016/j.rmed.2025.108132.
     PubMed     Abstract available
     
     
     
114. OISHI K, Yasui H, Inoue Y, Hozumi H, et al
     The role of arterial stiffness as assessed by the cardio-ankle vascular index in patients with chronic obstructive pulmonary disease.
     Respir Med. 2025;241:108078.
     PubMed     Abstract available
     
     
     
115. JIN C, Jin R, Liu D, Li Y, et al
     Genetically determined alpha-Klotho levels and causal association with aging-related lung diseases.
     Respir Med. 2025;241:108081.
     PubMed     Abstract available
     
     
     
116. LU L, Wu F, Tang G, Wan Q, et al
     Associations of small airway dysfunction assessed by impulse oscillometry with lung function decline and exacerbations in participants with chronic obstructive pulmonary disease: A prospective cohort study in China.
     Respir Med. 2025;241:108075.
     PubMed     Abstract available
     
     
     
117. ROBLES-HERNANDEZ RE, Montiel-Lopez F, Velazquez-Uncal M, Sansores RH, et al
     Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.
     Respir Med. 2025;241:108074.
     PubMed     Abstract available
     
     
     
118. ELIASON G, Ekstrom M, Montgomery S, Giezeman M, et al
     Associations of comorbid heart disease and depression/anxiety with multidimensional breathlessness in COPD - A cross-sectional study.
     Respir Med. 2025;241:108053.
     PubMed     Abstract available
     
     
     
119. MALVI A, Khatib MN, Ganesan S, Kaur M, et al
     Assessing the impact of electronic nicotine delivery systems on chronic obstructive pulmonary disease: A systematic review and meta-analysis.
     Respir Med. 2025;241:108059.
     PubMed     Abstract available
     
     
     
120. PISTENMAA CL, Hoffman EA, Prince MR, Hughes E, et al
     Platelet activation and COPD-related clinical and imaging characteristics: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.
     Respir Med. 2025;241:108058.
     PubMed     Abstract available
     
     
     
121. MENDES MA, Janssen DJ, Marques A
     Palliative care education as an integrated component of pulmonary rehabilitation: A real-world mixed-methods feasibility study.
     Respir Med. 2025;241:108034.
     PubMed     Abstract available
     
     
     
122. RO S, Aso S, Matsui H, Fushimi K, et al
     Association of once-daily single-device dual bronchodilators with prevention of rehospitalization for chronic obstructive pulmonary disease: A retrospective national inpatient database study.
     Respir Med. 2025;241:108033.
     PubMed     Abstract available
     
     
     
123. VOGELMEIER CF, Rabe KF, Bhatt SP, Hanania NA, et al
     Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
     Respir Med. 2025;241:108015.
     PubMed     Abstract available
     
     
     April 2025
124. TSE SM, Babatounde AK, Drouin O, Radhakrishnan D, et al
     The association between the stringency of COVID-19 public health mitigation strategies and pediatric asthma-related hospitalizations in Canada: an ecological study over 2 years.
     Respir Med. 2025;243:108125.
     PubMed     Abstract available
     
     
     
125. HUETHER KM, Lamb JM, Skelly J, Brigham E, et al
     Omega-3 Fatty Acid Intake Potentiates Bronchodilator Response in Patients with Obesity and Poorly Controlled Asthma.
     Respir Med. 2025 Apr 26:108131. doi: 10.1016/j.rmed.2025.108131.
     PubMed     Abstract available
     
     
     
126. GHERASIM A, Dietsch F, Odul F, Riff T, et al
     Efficacy of air cleaners to reduce allergic responses to cat: a randomized clinical trial using an environmental exposure chamber.
     Respir Med. 2025 Apr 15:108105. doi: 10.1016/j.rmed.2025.108105.
     PubMed     Abstract available
     
     
     
127. UNSAL H, Karaguzel D, Sarac BE, Aytekin ES, et al
     Inflammatory and oxidative stress markers in serum, urine and exhaled breath condensate: Relationship between asthma and obesity in children.
     Respir Med. 2025;242:108096.
     PubMed     Abstract available
     
     
     
128. ERTAN YAZAR E, Karadag EH, Eren FA, Demirci B, et al
     Validation of probable COPD as proposed by the Lancet Commission at a smoking cessation clinic.
     Respir Med. 2025;239:108004.
     PubMed     Abstract available
     
     
     
129. CHEN Z, Yue H, Gu Y, Xie C, et al
     Effect of traditional Chinese exercise on pulmonary function in middle-aged and older patients with stable chronic obstructive pulmonary disease: A randomized controlled trial.
     Respir Med. 2025;239:107997.
     PubMed     Abstract available
     
     
     
130. SUN F, Ye M, Jumahan A, Aainiwaier A, et al
     MHR as a promising predictor for coronary artery disease in COPD patients: Insights from a retrospective nomogram study.
     Respir Med. 2025;239:107993.
     PubMed     Abstract available
     
     
     
131. WARDYN PM, de Broucker V, Perez T, Demoulin-Alexikova S, et al
     Comparison of GLI-2021 standards with ECSC standards for static lung volume interpretation in patients with respiratory diseases.
     Respir Med. 2025;239:107988.
     PubMed     Abstract available
     
     
     
132. SONG C, Hao X, Critselis E, Panagiotakos D, et al
     The impact of electronic cigarette use on chronic obstructive pulmonary disease: A systematic review and meta-analysis.
     Respir Med. 2025;239:107985.
     PubMed     Abstract available
     
     
     
133. TAKIZAWA A, Shimada T, Chubachi S, Arai T, et al
     Exploring the pathophysiology of anemia in COPD: Insights from chest CT and longitudinal clinical data.
     Respir Med. 2025;240:108046.
     PubMed     Abstract available
     
     
     
134. PIHLAJA H, Piili RP, Nuutinen M, Saarto T, et al
     The use of specialist palliative care services differs in chronic obstructive pulmonary disease and interstitial lung disease: A national cohort study.
     Respir Med. 2025;240:108045.
     PubMed     Abstract available
     
     
     
135. DY ABC, Voraphani N, Spangenberg A, Belinsky SA, et al
     Circulating CC16, immune response to Mycoplasma pneumoniae and lung function: a population-based, multi-cohort study.
     Respir Med. 2025;240:108044.
     PubMed     Abstract available
     
     
     
136. ZHANG S, Lin J
     Association of circadian syndrome and lung health: A population-based cohort study.
     Respir Med. 2025;240:108031.
     PubMed     Abstract available
     
     
     
137. LIU Y, Huang J, Li E, Xiao Y, et al
     Analysis of research trends and hot spots on COPD biomarkers from the perspective of bibliometrics.
     Respir Med. 2025;240:108030.
     PubMed     Abstract available
     
     
     
138. SATO H, Nagano T, Suraya R, Hazama D, et al
     Reduction in circulating Endothelin-1 levels by inhaled COPD medications.
     Respir Med. 2025;240:108027.
     PubMed     Abstract available
     
     
     
139. SPITTLE DA, Pye A, Stanka J, De Soyza J, et al
     Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiency.
     Respir Med. 2025;240:108025.
     PubMed     Abstract available
     
     
     
140. DAVOUDI DASTENAEI F, Belyani S, Esfahani AJ, Bahari H, et al
     Association of lifestyle components with prevalence of chronic obstructive pulmonary disease (COPD): Findings of a cohort study.
     Respir Med. 2025;240:108013.
     PubMed     Abstract available
     
     
     
141. WEGLARZ K, Szczygiel E, Maslon A, Blaut J, et al
     Assessment of breathing patterns and voice of patients with COPD and dysphonia.
     Respir Med. 2025;240:108012.
     PubMed     Abstract available
     
     
     
142. CANO A, Esteban C, Larrea N, Iriberri M, et al
     Factors associated with short- and medium-term mortality after hospitalization for COPD exacerbation.
     Respir Med. 2025;240:108010.
     PubMed     Abstract available
     
     
     March 2025
143. STATEN T, Liu PH, Holt C, Alismail A, et al
     Effectiveness Of A Respiratory Therapist-Led, Community-Based Asthma Program In An Under resourced Rural Border Town In California.
     Respir Med. 2025 Mar 29:108071. doi: 10.1016/j.rmed.2025.108071.
     PubMed     Abstract available
     
     
     
144. GREIG R, Chan R, Lipworth B
     Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab.
     Respir Med. 2025;241:108072.
     PubMed    
     
     
     
145. MENZELLA F, Cottini M, Lombardi C, Senna G, et al
     A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction.
     Respir Med. 2025 Mar 25:108054. doi: 10.1016/j.rmed.2025.108054.
     PubMed     Abstract available
     
     
     
146. ECK S, Baumgartel A, Hapfelmeier A, Linde K, et al
     Effectiveness of an online asthma education program in adults with asthma in general practice: Results from a cluster randomised controlled trial.
     Respir Med. 2025;240:108041.
     PubMed     Abstract available
     
     
     
147. GUINOSSI RM, Bertagni Mingotti CF, Burch MO, Teixeira Soares LA, et al
     Residential greenness, respiratory symptoms and lung function in children, adolescents and adults with asthma: a cross-sectional study.
     Respir Med. 2025 Mar 11:108038. doi: 10.1016/j.rmed.2025.108038.
     PubMed     Abstract available
     
     
     
148. PELGROM AT, de Jongh IFHC, van den Aardweg JG, van Veen IHPAA, et al
     Analysis of the breathing pattern in patients with asthma during physical exercise: a cross-sectional study.
     Respir Med. 2025 Mar 11:108037. doi: 10.1016/j.rmed.2025.108037.
     PubMed     Abstract available
     
     
     
149. ORTIZ J, Staggers KA, Adrish M, Hanania NA, et al
     Asthma outcomes in a safety net hospital system: A comparative study to a national cohort.
     Respir Med. 2025;240:108032.
     PubMed     Abstract available
     
     
     
150. ZHAO C, Wang L, Zhang L, Wang Q, et al
     Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes.
     Respir Med. 2025 Mar 3:108024. doi: 10.1016/j.rmed.2025.108024.
     PubMed     Abstract available
     
     
     
151. GAO Q, Zhu H
     Investigating the risk factors for the coexistence of insomnia and its exacerbation in AECOPD.
     Respir Med. 2025;238:107987.
     PubMed     Abstract available
     
     
     
152. OTTESEN TG, Rovsing AH, Ulrik CS
     Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?
     Respir Med. 2025;238:107962.
     PubMed     Abstract available
     
     
     
153. CHOUDHARY OA, Dhawan J, Sohrabipour S, Semenchuk J, et al
     Assessment of online YouTube videos as a source of information and instruction for pulmonary rehabilitation.
     Respir Med. 2025;238:107968.
     PubMed     Abstract available
     
     
     
154. SOHRABIPOUR S, Ibrahim A, Dhawan J, Choudhary OA, et al
     Evaluation of online videos and websites on inspiratory muscle training for individuals with chronic lung disease.
     Respir Med. 2025;238:107967.
     PubMed     Abstract available
     
     
     
155. SHI W, Li T, Leng Y, Li Q, et al
     Global prevalence of fatigue in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
     Respir Med. 2025;238:107969.
     PubMed     Abstract available
     
     
     
156. CALZETTA L, Pistocchini E, Laitano R, Gholamalishahi S, et al
     Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on aging.
     Respir Med. 2025;238:107956.
     PubMed     Abstract available
     
     
     February 2025
157. SUN C, Li N, Xiao X, Zhang Q, et al
     Association between lipid accumulation products and asthma among adults: Data from National Health and Nutrition Examination Survey (NHANES) 2003-2018.
     Respir Med. 2025;240:108017.
     PubMed     Abstract available
     
     
     
158. TONE K
     Corrigendum to "Nodular-bronchiectatic pattern in pulmonary Nocardiosis: Immune status and treatment outcomes in a multicenter retrospective Study" [Respir. Med. 237 (2025) 107922].
     Respir Med. 2025 Feb 28:108009. doi: 10.1016/j.rmed.2025.108009.
     PubMed    
     
     
     
159. PORTACCI A, Iorillo I, Quaranta VN, Amendolara M, et al
     Diaphragm function in patients with asthma and healthy controls: a cross-sectional study.
     Respir Med. 2025 Feb 18:108008. doi: 10.1016/j.rmed.2025.108008.
     PubMed     Abstract available
     
     
     
160. JIANG P, Lu H, Jiang Y, Li F, et al
     Association between the triglyceride-glucose index and mortality in the asthma population.
     Respir Med. 2025 Feb 8:107989. doi: 10.1016/j.rmed.2025.107989.
     PubMed     Abstract available
     
     
     
161. CHIU SL, Chiang TI, Chen CL
     Identification and validation of SPP1 as a potential biomarker for COPD through comprehensive bioinformatics analysis.
     Respir Med. 2025;237:107953.
     PubMed     Abstract available
     
     
     
162. GARCIA-MOGUEL I, Martinez-Mesa A, Andujar-Espinosa R, Diaz-Campos R, et al
     The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis.
     Respir Med. 2025;237:107940.
     PubMed     Abstract available
     
     
     
163. WANG D, Hua L, Bai W, Guo M, et al
     Peripheral blood immune cell dynamics associate with growth of incidental indeterminate pulmonary nodules.
     Respir Med. 2025;237:107947.
     PubMed     Abstract available
     
     
     
164. MENDES LPS, Parreira VF, Rocha BC, Spencer LM, et al
     Glittre-ADL tests in three laps as an alternative to the five laps test.
     Respir Med. 2025;237:107945.
     PubMed     Abstract available
     
     
     
165. ELMIGER A, Marcin T, Bovet L, Brun P, et al
     Pulmonary rehabilitation and functional independence: Impact on survival in patients with fibrotic interstitial lung disease or chronic obstructive pulmonary disease.
     Respir Med. 2025;237:107933.
     PubMed     Abstract available
     
     
     
166. YANG Z, Zheng Y, Zhao J, Zhong Y, et al
     Impact of IL13 genetic polymorphisms on COPD susceptibility in the Chinese Han population.
     Respir Med. 2025;237:107923.
     PubMed     Abstract available
     
     
     January 2025
167. TIOTIU A, Migueres N, Gonzalez-Barcala FJ, Roux P, et al
     Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps.
     Respir Med. 2025;238:107979.
     PubMed     Abstract available
     
     
     
168. OKAY B, Hatipoglu HU, Okay ZU, Sahin K, et al
     COMPARING MESH AND COMPRESSOR NEBULIZERS IN PULMONARY FUNCTION TEST IN PEDIATRIC ASTHMA ATTACKS: A DOUBLE-BLIND RANDOMIZED COMPARATIVE CLINICAL TRIAL.
     Respir Med. 2025 Jan 28:107966. doi: 10.1016/j.rmed.2025.107966.
     PubMed     Abstract available
     
     
     
169. CAZZOLA M, Calzetta L, Matera MG, Rogliani P, et al
     Challenges in treating patients with comorbid asthma and bronchiectasis.
     Respir Med. 2025 Jan 21:107957. doi: 10.1016/j.rmed.2025.107957.
     PubMed     Abstract available
     
     
     
170. COSINI FF, Bagnasco D, Braido F, Canonica GW, et al
     Background therapy in severe asthma on monoclonal antibody treatment in real life.
     Respir Med. 2025;237:107944.
     PubMed     Abstract available
     
     
     
171. HORVATH A, Farkas A, Reti I, Ilyes N, et al
     Particularities of deposition of two ICS-LABA fixed dose combination dry powder aerosol drugs in the airways of COPD patients.
     Respir Med. 2025;236:107916.
     PubMed     Abstract available
     
     
     
172. XU H, Jiang X, Zeng Q, Li R, et al
     Application of e-Health tools in the assessment of inhalation therapy adherence in patients with chronic obstructive pulmonary disease: Scoping review coupled with bibliometric analysis.
     Respir Med. 2025;236:107898.
     PubMed     Abstract available
     
     
     
173. KRIMSKY WS, VanderLaan PA, Iding JS, Hunter DW, et al
     A quantitative method for assessing treatment-related changes within the airway mucosa in patients with chronic bronchitis.
     Respir Med. 2025;236:107889.
     PubMed     Abstract available
     
     
     
174. DELBRESSINE JM, Vaes AW, Stoop WAM, Van Ranst D, et al
     Reproducibility of three 6-min walk tests in patients with COPD referred for pulmonary rehabilitation.
     Respir Med. 2025;236:107884.
     PubMed     Abstract available
     
     
     
175. YAPPALPARVI A, Balaraman AK, Padmapriya G, Gaidhane S, et al
     Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis.
     Respir Med. 2025;236:107863.
     PubMed     Abstract available
     
     
     December 2024
176. HASEGAWA A, Tone K, Baba Y, Saito Z, et al
     Nodular-bronchiectatic Pattern in Pulmonary Nocardiosis: Immune Status and Treatment Outcomes in a Multicenter Retrospective Study.
     Respir Med. 2024 Dec 23:107922. doi: 10.1016/j.rmed.2024.107922.
     PubMed     Abstract available
     
     
     
177. BELHASSEN M, Marchal C, Deygas F, Jacoud F, et al
     In patients with asthma, obesity status is associated with poor control and high exacerbation rates, which are reversed after bariatric surgery.
     Respir Med. 2024;236:107917.
     PubMed     Abstract available
     
     
     
178. AJAZ M, Singh I, Vugic L, Jani R, et al
     The interplay of plant-based antioxidants, inflammation, and clinical outcomes in asthma: A systematic review.
     Respir Med. 2024;236:107918.
     PubMed     Abstract available
     
     
     
179. ALFAHL Z, Einarsson GG, Elborn JS, Gilpin DF, et al
     Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis.
     Respir Med. 2024;236:107906.
     PubMed     Abstract available
     
     
     
180. DONOHUE P, Connolly M, D'Alfonso M, Jackson G, et al
     Peripheral Airways Dysfunction Measured by Oscillometry Differentiates Asthma from Inducible Laryngeal Obstruction.
     Respir Med. 2024 Dec 2:107905. doi: 10.1016/j.rmed.2024.107905.
     PubMed     Abstract available
     
     
     
181. PETAT H, Marguet C
     Three-year outcome of a very young severe uncontrolled preschool wheezers cohort, a real-life study.
     Respir Med. 2024;235:107875.
     PubMed     Abstract available
     
     
     
182. SCIOSCIA G, Baraldi F, Bigoni T, Papi A, et al
     The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine.
     Respir Med. 2024;235:107865.
     PubMed     Abstract available
     
     
     November 2024
183. GEMICIOGLU B, Gokmen D, Can A, Sevinc C, et al
     Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry.
     Respir Med. 2024 Nov 29:107883. doi: 10.1016/j.rmed.2024.107883.
     PubMed     Abstract available
     
     
     
184. FARSHID S, Buckland BC, Shanmuganathan S, Low GK, et al
     End-tidal carbon dioxide, a point-of-care biomarker to assess severity in acute asthma: A systematic review.
     Respir Med. 2024 Nov 29:107891. doi: 10.1016/j.rmed.2024.107891.
     PubMed     Abstract available
     
     
     
185. YASUI H, Oishi K, Nihashi F, Furuhashi K, et al
     Factors associated with uncontrolled severe asthma in the biologic era.
     Respir Med. 2024;236:107881.
     PubMed     Abstract available
     
     
     
186. ERRASTI VIADER J, Martinez Gonzalez MA, Campo Ezquibela A, Bes-Rastrollo M, et al
     Dietary patterns and asthma incidence in adult population. Systematic review and meta-analysis.
     Respir Med. 2024 Nov 19:107861. doi: 10.1016/j.rmed.2024.107861.
     PubMed     Abstract available
     
     
     
187. GANGEMI AJ, Dass CA, Zhao H, Patel M, et al
     Advanced Emphysema Leads to High False Positivity Rate for Pneumothorax in Point of Care Ultrasound.
     Respir Med. 2024 Nov 16:107860. doi: 10.1016/j.rmed.2024.107860.
     PubMed     Abstract available
     
     
     
188. SESHADRI N, Faig W, Young LR, Hill DA, et al
     Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma.
     Respir Med. 2024 Nov 15:107867. doi: 10.1016/j.rmed.2024.107867.
     PubMed     Abstract available
     
     
     
189. GOMEZ LF, Kinnee E, Kaufman JD, Young MT, et al
     Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
     Respir Med. 2024;234:107853.
     PubMed     Abstract available
     
     
     
190. HUG S, Cavalheri V, Hill K, Gucciardi DF, et al
     Road to referral success in COPD: Enhancing patient engagement through dedicated conversations about pulmonary rehabilitation programs.
     Respir Med. 2024;233:107790.
     PubMed     Abstract available
     
     
     
191. LI C, Lian X, He J, Gao X, et al
     Association of computed tomography-derived pectoralis muscle area and density with disease severity and respiratory symptoms in patients with chronic obstructive pulmonary disease: A case-control study.
     Respir Med. 2024;233:107783.
     PubMed     Abstract available
     
     
     
192. GRASL MT, Agusti A, Azizzadeh M, Karimi A, et al
     Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime.
     Respir Med. 2024;233:107779.
     PubMed     Abstract available
     
     
     
193. HAMADA R, Tanabe N, Oshima Y, Yoshioka Y, et al
     Phase angle measured by bioelectrical impedance analysis in patients with chronic obstructive pulmonary disease: Associations with physical inactivity and frailty.
     Respir Med. 2024;233:107778.
     PubMed     Abstract available
     
     
     
194. HANSEN KK, Hilberg O, Lokke A
     High prevalence of undiagnosed and treatment-requiring obstructive sleep apnea and nocturnal desaturation in outpatients with severe chronic obstructive pulmonary disease.
     Respir Med. 2024;233:107771.
     PubMed    
     
     
     
195. ALQAHTANI JS, Arowosegbe A, Aldhahir AM, Alghamdi SM, et al
     Prevalence and burden of loneliness in COPD: A systematic review and meta-analysis.
     Respir Med. 2024;233:107768.
     PubMed     Abstract available
     
     
     
196. IGNACIO CARLOTTO C, Bernardes S, Zanella P, Silva FM, et al
     Dietary patterns and risk of Chronic Obstructive Pulmonary Disease (COPD) and clinical outcomes in diagnosed patients: A scoping review.
     Respir Med. 2024;233:107773.
     PubMed     Abstract available
     
     
     
197. BAKKER JT, Hartman JE, Klooster K, Charbonnier JP, et al
     Endobronchial valve treatment improves chest-CT diaphragm configuration in COPD.
     Respir Med. 2024;234:107856.
     PubMed     Abstract available
     
     
     
198. BOERSMA R, Bakker JT, de Vries M, Raveling T, et al
     Defining a phenotype of severe COPD patients who develop chronic hypercapnia.
     Respir Med. 2024;234:107850.
     PubMed     Abstract available
     
     
     
199. BUCHARDT STE, Weinreich UM, Lindgren FL, Lauridsen MD, et al
     Patient characteristics and mortality across diagnostic settings in COPD.
     Respir Med. 2024;234:107843.
     PubMed     Abstract available
     
     
     
200. SAADI R, Rangwala R, Shaikh H, Laghi F, et al
     The effects of noninvasive respiratory support on swallowing physiology, airway protection, and respiratory-swallow pattern in adults: A systematic review.
     Respir Med. 2024;234:107844.
     PubMed     Abstract available
     
     
     
201. PHANTAYUTH D, Chuaychoo B, Supaporn S, Nana A, et al
     Effectiveness of a 12-week combining tai chi and yoga program on pulmonary function and functional fitness in COPD patients.
     Respir Med. 2024;234:107842.
     PubMed     Abstract available
     
     
     
202. HOU XF, Hou CG
     Association between acute tobacco exposure and fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease: National health and Nutrition Examination Survey (NHANES) 2007-2012.
     Respir Med. 2024;234:107831.
     PubMed     Abstract available
     
     
     
203. CHOATE R, Holm KE, Sandhaus RA, Mannino DM, et al
     Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPD.
     Respir Med. 2024;234:107838.
     PubMed     Abstract available
     
     
     
204. TOFOLI TM, Santin L, Medeiros L, Silva H, et al
     Determinant factors of sedentary time in individuals with COPD.
     Respir Med. 2024;234:107839.
     PubMed     Abstract available
     
     
     
205. TAN DJ, Finlay P, Siu H, Fan IM, et al
     Impaired diffusing capacity and COPD incidence in adults with symptoms and normal spirometry.
     Respir Med. 2024;234:107832.
     PubMed     Abstract available
     
     
     
206. COX NS, Barton C, Bondarenko J, Clark R, et al
     Characterizing pulmonary rehabilitation referrals from primary care.
     Respir Med. 2024;234:107822.
     PubMed     Abstract available
     
     
     
207. SHANMUGAVEL GEETHA H, Teo YX, Ravichandran S, Perkit NR, et al
     Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus.
     Respir Med. 2024;234:107819.
     PubMed     Abstract available
     
     
     
208. ZHU Z
     Advancements in automated classification of chronic obstructive pulmonary disease based on computed tomography imaging features through deep learning approaches.
     Respir Med. 2024;234:107809.
     PubMed     Abstract available
     
     
     
209. SHI Q, Xu J, Zeng L, Lu Z, et al
     A nomogram for predicting short-term mortality in ICU patients with coexisting chronic obstructive pulmonary disease and congestive heart failure.
     Respir Med. 2024;234:107803.
     PubMed     Abstract available
     
     
     
210. JANG JG, Kim Y, Shin SH, Min KH, et al
     The role of FEV(1)/FVC in the prediction of acute exacerbation of COPD.
     Respir Med. 2024;234:107780.
     PubMed     Abstract available
     
     
     October 2024
211. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
     Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
     Respir Med. 2024 Oct 29:107846. doi: 10.1016/j.rmed.2024.107846.
     PubMed     Abstract available
     
     
     
212. CAZZOLA M, Ora J, Calzetta L, Rogliani P, et al
     beta-Blockers and Asthma: Surprising Findings from the FAERS Database.
     Respir Med. 2024 Oct 26:107849. doi: 10.1016/j.rmed.2024.107849.
     PubMed     Abstract available
     
     
     
213. BOURBEAU J
     In COPD- right treatment, right patient, right time, right approach?
     Respir Med. 2024;232:107769.
     PubMed    
     
     
     
214. PANTAZOPOULOS I, Boutlas S, Mavrovounis G, Papalampidou A, et al
     Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial.
     Respir Med. 2024;232:107762.
     PubMed     Abstract available
     
     
     
215. LAURIDSEN MD, Grontved S, Fosbol E, Johnsen SP, et al
     Treatment intensity level as a proxy for severity of chronic obstructive pulmonary disease: A risk stratification tool.
     Respir Med. 2024;232:107742.
     PubMed     Abstract available
     
     
     
216. ZHENG K, Tang L, Wang X, Chen L, et al
     The risk factors for chronic cough in children: A meta-analysis covering five continents.
     Respir Med. 2024;232:107752.
     PubMed     Abstract available
     
     
     
217. WU W, Guan L, Guo B, Yang Y, et al
     Respiratory physiological mechanism of two types of equal-intensity inspiratory muscle training in stable patients with chronic obstructive pulmonary disease.
     Respir Med. 2024;232:107747.
     PubMed     Abstract available
     
     
     
218. WU WW
     Association of naples prognostic score and lung health: A population-based study.
     Respir Med. 2024;232:107751.
     PubMed     Abstract available
     
     
     
219. DELACOSTE FBC, Goulart CDL, Guidoti AB, Turck P, et al
     Evaluating the impact of short-term nitrate-rich dietary supplementation on endothelial function in COPD: A randomized crossover study.
     Respir Med. 2024;232:107745.
     PubMed     Abstract available
     
     
     
220. MUNOZ MONTIEL A, Ruiz-Esteban P, Domenech Del Rio A, Valdivielso P, et al
     The effect of pulmonary rehabilitation on cardiovascular risk, oxidative stress and systemic inflammation in patients with COPD.
     Respir Med. 2024;232:107740.
     PubMed     Abstract available
     
     
     September 2024
221. HAMELMANN E, Csonka P, Roberts G, Vogelberg C, et al
     High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.
     Respir Med. 2024 Sep 24:107812. doi: 10.1016/j.rmed.2024.107812.
     PubMed     Abstract available
     
     
     
222. HAKANSSON KEJ, Alabdulkarim N, Guerrero SC, Backer V, et al
     Real-world phenotyping and risk assessment of childhood asthma burden using national registries.
     Respir Med. 2024;234:107808.
     PubMed     Abstract available
     
     
     
223. NOPSOPON T, Brown A, Hahn G, Rank M, et al
     Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics.
     Respir Med. 2024 Sep 9:107802. doi: 10.1016/j.rmed.2024.107802.
     PubMed     Abstract available
     
     
     
224. FAT M, Andersen T, Fazio JC, Park SC, et al
     Association of bronchial disease on CT imaging and clinical definitions of chronic bronchitis in a single-center COPD phenotyping study.
     Respir Med. 2024;231:107733.
     PubMed     Abstract available
     
     
     
225. BISHOP JA, Spencer LM, Dwyer TJ, McKeough ZJ, et al
     Patterns of physical activity of people with COPD during participation in a pulmonary rehabilitation program.
     Respir Med. 2024;231:107724.
     PubMed     Abstract available
     
     
     
226. SCHAFAUSER NS, Sampaio LMM, Heubel AD, Kabbach EZ, et al
     Influence of heart failure (HF) comorbidity in chronic obstructive pulmonary disease (COPD) and isolated forms of HF and COPD on cardiovascular function during hospitalization.
     Respir Med. 2024;231:107731.
     PubMed     Abstract available
     
     
     
227. WSHAH A, Alqatarneh N, Al-Nassan S, Goldstein R, et al
     Factors related to the implementation of pulmonary rehabilitation in Jordan: Perspective of healthcare professionals.
     Respir Med. 2024;231:107728.
     PubMed     Abstract available
     
     
     
228. GUO L, Bilimoria SN, Kikuchi R, Hao A, et al
     Prevalence, incidence, and risk of chronic obstructive pulmonary disease among psoriasis patients.
     Respir Med. 2024;231:107729.
     PubMed     Abstract available
     
     
     
229. SMIRNOVA N, Cross SH, Light A, Kavalieratos D, et al
     Racial differences in palliative care and hospice among adults with chronic obstructive pulmonary disease.
     Respir Med. 2024;231:107719.
     PubMed    
     
     
     
230. QUEZADA WA, Angulo D, Murray S, Joo M, et al
     Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.
     Respir Med. 2024;231:107695.
     PubMed     Abstract available
     
     
     
231. RISEBROUGH NA, Mursleen S, Ndirangu K, Shah D, et al
     The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trial.
     Respir Med. 2024;231:107694.
     PubMed     Abstract available
     
     
     August 2024
232. WHARTON R, Mathis N, Wang JG, Meislin R, et al
     Feasibility of Remote Spirometry Monitoring of Asthma in Pregnancy.
     Respir Med. 2024 Aug 24:107782. doi: 10.1016/j.rmed.2024.107782.
     PubMed    
     
     
     
233. WEBB EM, Holland AE, Chang AB, Burr L, et al
     Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registry.
     Respir Med. 2024;233:107777.
     PubMed     Abstract available
     
     
     
234. TERL M, Diamant Z, Kosturiak R, Jesenak M, et al
     Choosing the right biologic treatment for individual patients with severe asthma - lessons learnt from Picasso.
     Respir Med. 2024 Aug 22:107766. doi: 10.1016/j.rmed.2024.107766.
     PubMed     Abstract available
     
     
     
235. NORWEG A, Oh C, Nolan A
     Onion Consumption is Protective Against Asthma Risk in Children: ROAD to Health Population-based Cohort Study.
     Respir Med. 2024 Aug 11:107767. doi: 10.1016/j.rmed.2024.107767.
     PubMed    
     
     
     
236. DITTRICH AS, Kontogianni K, Unterschemmann AS, De Rossi S, et al
     Efficacy and safety of simultaneous combined Zephyr and Spiration valve therapy in patients with advanced pulmonary emphysema.
     Respir Med. 2024 Aug 2:107760. doi: 10.1016/j.rmed.2024.107760.
     PubMed     Abstract available
     
     
     
237. KIZMAZ E, Telli Atalay O, Cetin N, Ugurlu E, et al
     Virtual reality for COPD exacerbation: A randomized controlled trial.
     Respir Med. 2024;230:107696.
     PubMed     Abstract available
     
     
     
238. KARJALAINEN J, Vartiainen V, Tikkakoski A, Malmberg LP, et al
     Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
     Respir Med. 2024;230:107693.
     PubMed     Abstract available
     
     
     
239. NGUYEN KT, Brooks D, Macedo LG, Ellerton C, et al
     Balance measures for fall risk screening in community-dwelling older adults with COPD: A longitudinal analysis.
     Respir Med. 2024;230:107681.
     PubMed     Abstract available
     
     
     
240. JOO H, Yoon HK, Hwang YI, Kim SH, et al
     Application of the Lancet Commission COPD classification to COPD Cohort Population in South Korea.
     Respir Med. 2024;230:107679.
     PubMed     Abstract available
     
     
     July 2024
241. BULT L, Thelen JC, Rauh SP, Veen JCCMI', et al
     Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study.
     Respir Med. 2024 Jul 9:107720. doi: 10.1016/j.rmed.2024.107720.
     PubMed     Abstract available
     
     
     
242. LOCCI C, Puci MV, Saderi L, Sotgiu G, et al
     The complex link between sleep-disordered breathing and asthma control in pediatric patients: a cross-sectional study.
     Respir Med. 2024 Jul 2:107730. doi: 10.1016/j.rmed.2024.107730.
     PubMed     Abstract available
     
     
     
243. SORIANO JB, Polverino F
     Sexual activity and respiratory disease: A systematic review.
     Respir Med. 2024;228:107665.
     PubMed     Abstract available
     
     
     
244. LIAO KM, Chiu CC, Lu HY
     The risk of secondary spontaneous pneumothorax in patients with chronic obstructive pulmonary disease in Taiwan.
     Respir Med. 2024;228:107672.
     PubMed     Abstract available
     
     
     
245. LI L, Wang L, Zhang L, Zhao C, et al
     Frailty and in-hospital mortality in older patients with acute exacerbation of COPD: A real-world prospective cohort study.
     Respir Med. 2024;228:107663.
     PubMed     Abstract available
     
     
     
246. YOUNES A, Mandigout S, Robin L, Borel B, et al
     What kind of non-pharmacological strategy for reducing sedentary behavior in COPD? Data from a scoping review.
     Respir Med. 2024;228:107662.
     PubMed     Abstract available
     
     
     June 2024
247. VISSER CD, Faay MRA, Ozdemir A, Guchelaar HJ, et al
     Short-acting beta(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.
     Respir Med. 2024 Jun 25:107723. doi: 10.1016/j.rmed.2024.107723.
     PubMed     Abstract available
     
     
     
248. PACKHAM S, Odling M, Bossios A, Konradsen JR, et al
     Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
     Respir Med. 2024;231:107714.
     PubMed     Abstract available
     
     
     
249. HE ZF, Lin SZ, Pan CX, Chen ZM, et al
     The roles of bacteria and viruses in COPD-Bronchiectasis association: A prospective cohort study.
     Respir Med. 2024 Jun 7:107692. doi: 10.1016/j.rmed.2024.107692.
     PubMed     Abstract available
     
     
     
250. MARTINEZ-GONZALEZ CL, Camargo Fajardo MCC, Martinez-Ortiz EJ, Segura Medina P, et al
     A soft systems approach of asthma management in children based on therapeutic education and e-learning.
     Respir Med. 2024 Jun 4:107691. doi: 10.1016/j.rmed.2024.107691.
     PubMed     Abstract available
     
     
     
251. ISLAM N, Reid D
     Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens.
     Respir Med. 2024;227:107661.
     PubMed     Abstract available
     
     
     
252. RAZJOUYAN J, Hanania NA, Nowakowski S, Agrawal R, et al
     Identification of sleep phenotypes in COPD using machine learning-based cluster analysis.
     Respir Med. 2024;227:107641.
     PubMed     Abstract available
     
     
     
253. CHOUDHURY P, Dasgupta S, Kar A, Sarkar S, et al
     Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH.
     Respir Med. 2024;227:107658.
     PubMed     Abstract available
     
     
     
254. KOSTER TD, Shah PL, Valipour A, Criner GJ, et al
     Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr(R) valves.
     Respir Med. 2024;227:107639.
     PubMed     Abstract available
     
     
     
255. GOMES VMR, Pires MC, Delfino Pereira P, Schwarzbold AV, et al
     AB(2)CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units.
     Respir Med. 2024;227:107635.
     PubMed     Abstract available
     
     
     
256. ZELL-BARAN LM, Krefft SD, Strand M, Rose CS, et al
     Longitudinal changes in lung function following post-9/11 military deployment in symptomatic veterans.
     Respir Med. 2024;227:107638.
     PubMed     Abstract available
     
     
     
257. YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
     Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.
     Respir Med. 2024;227:107633.
     PubMed     Abstract available
     
     
     
258. LAPI F, Marconi E, Lombardo FP, Cricelli I, et al
     Development and validation of a prediction score to assess the risk of incurring in COPD-related exacerbations: a population-based study in primary care.
     Respir Med. 2024;227:107634.
     PubMed     Abstract available
     
     
     May 2024
259. LO CASTO M, Marino S, Zammuto MM, Tomasello A, et al
     Patients with bronchiectasis have a lower combined risk of cardiovascular risk factors and cardiovascular comorbidity compared to patients with COPD.
     Respir Med. 2024;229:107683.
     PubMed     Abstract available
     
     
     
260. AL-AHMAD M, Al Zaabi A, Madkour A, Alqaraghuli HA, et al
     Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.
     Respir Med. 2024 May 21:107674. doi: 10.1016/j.rmed.2024.107674.
     PubMed     Abstract available
     
     
     
261. AKSAMIT TR, Lapinel NC, Choate R, Feliciano J, et al
     Association between bronchiectasis exacerbations and longitudinal changes in FEV(1) in patients from the US Bronchiectasis and NTM Research Registry.
     Respir Med. 2024 May 9:107660. doi: 10.1016/j.rmed.2024.107660.
     PubMed     Abstract available
     
     
     
262. ZHOU Y, Duan S, Zhang L, Peng F, et al
     Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China.
     Respir Med. 2024;226:107632.
     PubMed     Abstract available
     
     
     
263. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
     The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
     Respir Med. 2024;226:107609.
     PubMed    
     
     
     
264. STOUSTRUP AL, Janssen DJA, Nakken N, Wouters EFM, et al
     Association of inadequate social support and clinical outcomes in patients with chronic obstructive pulmonary disease - A cross-sectional study.
     Respir Med. 2024;226:107625.
     PubMed     Abstract available
     
     
     
265. LUNDELL S, Isaksson U, Coe AB, Harrison SL, et al
     Swedish translation and psychometric testing of the Self-Conscious Emotions in COPD Questionnaire.
     Respir Med. 2024;226:107624.
     PubMed     Abstract available
     
     
     
266. LUU B, Chinnadurai A, Choudhary O, Breede N, et al
     A comprehensive evaluation of online inhaler use techniques for obstructive airway disease.
     Respir Med. 2024;226:107607.
     PubMed     Abstract available
     
     
     
267. ZYSMAN M, Coquelin A, Le Guen N, Solomiac A, et al
     Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study.
     Respir Med. 2024;226:107606.
     PubMed     Abstract available
     
     
     April 2024
268. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
     Are biologics effective on lung hyperinflation in patients with resistant asthma?
     Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
     PubMed    
     
     
     
269. CAZZOLA M, Maniscalco M
     Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
     Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
     PubMed    
     
     
     
270. JI H, Tan LD, Hafzella G, Nguyen N, et al
     Navigating Biologic Therapies in Elderly Asthma.
     Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
     PubMed     Abstract available
     
     
     
271. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
     Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
     Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
     PubMed     Abstract available
     
     
     
272. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
     Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
     Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
     PubMed     Abstract available
     
     
     
273. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
     Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
     Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
     PubMed     Abstract available
     
     
     
274. FARKAS A, Horvath A, Reti I, Ilyes N, et al
     Comparative study of the inhalation parameters of COPD patients through NEXThaler(R) and Ellipta(R) dry powder inhalers.
     Respir Med. 2024;224:107576.
     PubMed     Abstract available
     
     
     
275. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
     The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
     Respir Med. 2024;224:107564.
     PubMed     Abstract available
     
     
     
276. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
     Predicting exacerbations in COPD in the Danish general population.
     Respir Med. 2024;224:107557.
     PubMed     Abstract available
     
     
     
277. BROCKWAY K, Ahmed S
     Beyond breathing: Systematic review of global chronic obstructive pulmonary disease guidelines for pain management.
     Respir Med. 2024;224:107553.
     PubMed     Abstract available
     
     
     
278. LAI K, Sun D, Dai R, Samoro R, et al
     Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
     Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
     PubMed     Abstract available
     
     
     
279. GOTO T, Banno M, Kimura R
     Revisiting the use of high flow nasal cannula in acute exacerbation of COPD and conclusion of trial.
     Respir Med. 2024;225:107602.
     PubMed    
     
     
     
280. LORENZANA I, Galera R, Casitas R, Martinez-Ceron E, et al
     Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients.
     Respir Med. 2024;225:107597.
     PubMed     Abstract available
     
     
     
281. XU X, Yin J, Yang Y, Liu H, et al
     Advances in co-pathogenesis of the united airway diseases.
     Respir Med. 2024;225:107580.
     PubMed     Abstract available
     
     
     
282. STEGER M, Canuet M, Enache I, Goetsch T, et al
     Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
     Respir Med. 2024;225:107585.
     PubMed     Abstract available
     
     
     
283. BELL K, Lawson J, Penz E, Cammer A, et al
     Systematic review of tailored dietary advice and dietitian involvement in the treatment of chronic obstructive pulmonary disease (COPD).
     Respir Med. 2024;225:107584.
     PubMed     Abstract available
     
     
     
284. VERWEEL L, Packham T, Goldstein R, Brooks D, et al
     Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.
     Respir Med. 2024;225:107588.
     PubMed     Abstract available
     
     
     
285. LUO L, Tang J, Du X, Li N, et al
     Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians.
     Respir Med. 2024;225:107586.
     PubMed     Abstract available
     
     
     March 2024
286. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
     A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
     Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
     PubMed     Abstract available
     
     
     
287. JEONG J, Nam YH, Sim DW, Kim BK, et al
     Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
     Respir Med. 2024;225:107598.
     PubMed     Abstract available
     
     
     
288. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
     Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
     Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
     PubMed     Abstract available
     
     
     
289. NIERI D, Morani C, De Francesco M, Gaeta R, et al
     Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease.
     Respir Med. 2024;223:107563.
     PubMed     Abstract available
     
     
     
290. LAI Y, Cavalheri V, Sawyer A, Hill K, et al
     Exercise training initiated early during hospitalisation in individuals with chronic obstructive pulmonary disease is safe and improves exercise capacity and physical function at hospital discharge: A systematic review and meta-analysis.
     Respir Med. 2024;223:107554.
     PubMed     Abstract available
     
     
     
291. LAU F, Schupp T, Schmitt A, Reinhardt M, et al
     Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction.
     Respir Med. 2024;223:107536.
     PubMed     Abstract available
     
     
     February 2024
292. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
     Impact of biologics on lung hyperinflation in patients with severe asthma.
     Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
     PubMed     Abstract available
     
     
     
293. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
     No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
     Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
     PubMed     Abstract available
     
     
     November 2023
294. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
     A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
     Respir Med. 2023;219:107435.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.